Clinical Trial Update: Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating expression of pro- and anti-inflammatory cytokines during anti-PCSK9 therapy in familial hypercholesterolemia; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• anti-PCSK9 (PCSK9 inhibitor)

Snippet

Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Conditions: Hypercholesterolemia, Familial | Phase 4 | Status: COMPLETED